Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medtronic Cardiac Rhythm and Heart Failure
With
Medtronic
The OMNI results demonstrate the importance of Medtronic's ongoing efforts to increase adoption of evidence based shock-reduction programming strategies. Longer VF NID (number of intervals to detect in the VF zone) should be utilized with the Anti-tachycardia Pacing (ATP) During Charging Feature. ATP during Charging allows physicians to treat with ATP without delay to shock. Therefore, VF NID may be extended to allow episodes the chance to self-terminate immediately to shock by use of the ATP during the charging feature.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Implant of new or replacement study device. Enrollment must occur no later than 40 days post-implant.
Study participants must be 18 years of age or older.
You may not be if
Study participants enrolled or intend to participate in another clinical device trial during the course of this study that required specific treatment or programming.
Study participants unwilling and unable to comply with follow-up schedule.
Clareo Health | OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.
